REISEGOLD Tablets against travel sickness, 10 pcs

Instructions for use for REISEGOLD Tablets against travel sickness, 10 pcs

Detailed instructions for REISEGOLD Tablets against travel sickness, 10 pcs

Field of use

Travel gold tabs against travel dubes (pack size: 10 pcs) are used for effective prevention and treatment of travel problems, such as that occur, for example, in the form of travel dubis when traveling by car, aircraft, ship, train or bus.

Mode of action

Travel gold tabs against travel dubes (pack size: 10 pcs) stabilize the equilibrium center and dampen the nausea. This prevents dizziness and nausea. The active ingredient blocks receptors for the messenger substance histamine. This blockade reduces veneer expansion and increased blood flow to the smallest hair vessels (capillaries), which ultimately cause travel problems. Already 15 to 30 minutes after taking a tablet, a relief of the rashes can be felt. The effect lasts 3 to 6 hours. Travel gold tabs against travel dubes (pack size: 10 pc) are divisible, so that individual, and also for shorter travel times, the dosage can be easily changed.

Active ingredients / ingredients / ingredients

50 mg dimen hydrinate
Calcium hydrogen phosphate 2-water auxiliary material (+)
Carboxymethylar, sodium salt auxiliary material (+)
Cellulose powder Hedge substance (+)
Lactose 1-water auxiliary substance (+)
Magnesium stair auxiliary material (+)
Silicium dioxide, high disperser auxiliary substance (+)

Contradictions

Travel gold tabs against travel dubes (package size: 10 pc) may not be used if they are incompatible (allergic) compared to one of the components of travel gold tabs against travel dubes (pack size: 10 pc).

dosage

If necessary, take a tablet with a little liquid immediately before the start of the trip. Travel gold tabs against travel dubes (pack size: 10 pcs) is approved for children from 6 years.

Taking

• Take the tablet (s) unscrewed with plenty of liquid before meals.

Patient information

• Warnings and Precautions
  • Please speak to your doctor or pharmacist before taking the medicine. The preparation may only be taken after consultation with the doctor at
    • limited liver function,
    • Heart rhythm disorders (e.g,
    • Potassium or magnesium deficiency,
    • slow heartbeat (bradycardia),
    • certain heart disease (congenital QT syndrome or other clinically significant heart damage, in particular circulatory disorders of the coronary arteries, arousal disorders, arrhythmias),
    • simultaneous use of medicines that also extend the so-called QT interval in the EKG or lead to hypocalaemia,
    • chronic breathing difficulties and asthma,
    • Consequence at the output of the stomach (pylorus stenosis).
  • Children
    • The medicine is not suitable for children under the age of 6.

 

• Wateriness and operating machines
  • Sleepiness, memory disorders and reduced ability to concentrate can have a negative impact on the ability to drive or the ability to operate machines. This applies in particular to inadequate sleeping time, when treating treatment and preparation change as well as in interaction with alcohol.

Pregnancy

• If you are pregnant or breastfeed, or if you suspect that you are pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before taking this drug.
• Pregnancy
  • The preparation must not be taken during pregnancy, since dimen hydrinate can trigger contractions prematurely.
• Breastfeeding
  • Dimenhydrinate merges into breast milk and should therefore not be taken during breastfeeding.

Hints

Miscellaneous

- After using dimen hydrinate, light sensitivity to the skin can occur; therefore avoid direct sunlight.
- Sleepiness, memory disorders and reduced ability to concentrate can have a negative impact on the ability to drive or the ability to work with machines. This applies particularly inadequate sleeping time, when the treatment starts and in interaction with alcohol.
- No alcohol should be drunk during treatment with dimen hydrinate.
- Dimenhydrinate can possibly lead to incorrect test results with allergy tests.
- After a longer daily application, sudden termination of the treatment can temporarily occur sleep disorders. Therefore, treatment should be ended in these cases by gradually reducing the dose.
- Dimenhydrinate is not suitable for the sole treatment of nausea and vomiting in chemotherapy.

Manufacturer:  CHEPLAPHARM Arzneimittel GmbH, Bahnhofstrasse 1a, 17498 Mesekenhagen